These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21968416)

  • 21. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
    Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
    Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
    Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
    Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
    Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
    Omran OM; Thabet M
    Ultrastruct Pathol; 2012 Apr; 36(2):108-16. PubMed ID: 22471433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
    Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
    J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.
    Perentes JY; Kirkpatrick ND; Nagano S; Smith EY; Shaver CM; Sgroi D; Garkavtsev I; Munn LL; Jain RK; Boucher Y
    Cancer Res; 2011 Jul; 71(13):4527-38. PubMed ID: 21571860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
    Kikuchi R; Noguchi T; Takeno S; Kubo N; Uchida Y
    Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
    Kang JC; Chen JS; Lee CH; Chang JJ; Shieh YS
    J Surg Oncol; 2010 Sep; 102(3):242-8. PubMed ID: 20740582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
    Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD
    FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.